Fulvestrant contains not less than 97.0% and not more than 102.0% of C32H47F5O3S, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

氟維司瓊
Fulvestrant

申請商
丞泰企業有限公司 
適應症
抗癌藥
含量
發證日期
2023-09-28